Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$88.33
-1.1%
$89.65
$69.51
▼
$110.68
$112.97B0.588.60 million shs4.38 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$284.99
-0.3%
$266.97
$195.90
▼
$290.25
$686.27B0.227.93 million shs2.31 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$41.89
+0.6%
$40.09
$35.12
▼
$64.16
$187.02B0.716.29 million shs9.53 million shs
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$43.64
-1.9%
$40.16
$24.01
▼
$44.57
$50.88B0.976.84 million shs2.90 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+6.70%-3.30%-4.92%+14.78%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.00%+3.18%+7.42%-7.21%-13.62%
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
0.00%+4.70%+7.42%+21.86%+75.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$88.33
-1.1%
$89.65
$69.51
▼
$110.68
$112.97B0.588.60 million shs4.38 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$284.99
-0.3%
$266.97
$195.90
▼
$290.25
$686.27B0.227.93 million shs2.31 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$41.89
+0.6%
$40.09
$35.12
▼
$64.16
$187.02B0.716.29 million shs9.53 million shs
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$43.64
-1.9%
$40.16
$24.01
▼
$44.57
$50.88B0.976.84 million shs2.90 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+6.70%-3.30%-4.92%+14.78%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.00%+3.18%+7.42%-7.21%-13.62%
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
0.00%+4.70%+7.42%+21.86%+75.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.92
Moderate Buy$107.5420.34% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$275.92-3.45% Downside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4442.70% Upside
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
2.80
Moderate Buy$48.158.17% Upside

Current Analyst Ratings Breakdown

Latest TEVA, JNJ, CVS, and NVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/13/2026
CVS Health Corporation stock logo
CVS
CVS Health
Set Price Target$106.00
11/13/2026
CVS Health Corporation stock logo
CVS
CVS Health
Reiterated RatingOutperform
11/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetOverweight$123.00 ➝ $112.00
11/12/2026
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
Boost Price TargetOverweight$44.00 ➝ $56.00
11/9/2026
CVS Health Corporation stock logo
CVS
CVS Health
UpgradeHold (C+) ➝ Buy (B-)
11/6/2026
CVS Health Corporation stock logo
CVS
CVS Health
Set Price Target$103.00
11/5/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetBuy$118.00 ➝ $107.00
11/5/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetOutperform$112.00 ➝ $104.00
11/5/2026
CVS Health Corporation stock logo
CVS
CVS Health
Lower Price TargetOverweight$108.00 ➝ $107.00
11/5/2026
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
Boost Price TargetOutperform$45.00 ➝ $52.00
11/4/2026
CVS Health Corporation stock logo
CVS
CVS Health
Reiterated RatingBuy$103.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$420.61B0.27$14.89 per share6.00$59.38 per share1.51
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B7.30$14.12 per share20.24$33.85 per share8.44
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$333.65B0.56$4.69 per share8.88$6.58 per share6.33
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$17.26B3.01$3.73 per share11.93$6.88 per share6.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$8.5910.4010.340.782.62%13.65%4.20%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$6.6043.3024.722.8216.20%31.64%13.04%1/26/2027 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$3.9710.4912.071.4333.99%53.52%19.49%2/3/2027 (Estimated)
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$1.41B$0.43103.5314.453.852.94%33.20%6.59%1/27/2027 (Estimated)

Latest TEVA, JNJ, CVS, and NVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026 & Investor update
CVS Health Corporation stock logo
CVS
CVS Health
$1.65$2.09+$0.44$1.68$104.72 billion$108.40 billion
11/3/2026Q3 2026
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
$0.72$0.86+$0.14$0.20$4.23 billion$4.40 billion
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.53$2.59+$0.06$0.09$25.38 billion$25.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.662.98%+5.87%30.97%4 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.361.88%+5.25%81.21%64 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.811.94%+21.74%20.40%N/A
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
N/AN/AN/AN/AN/A

Latest TEVA, JNJ, CVS, and NVO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.15%11/24/202611/24/202612/8/2026
9/30/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66502.81%10/22/202610/22/202611/2/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.71
0.85
0.66
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.02
0.74
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.54
0.84
0.64
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
1.59
0.95
0.74

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
54.05%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
0.54%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
33,9501.17 billion1.16 billionOptionable

Recent News About These Companies

HC Wainwright Has Positive Forecast for TEVA FY2026 Earnings
Sector Update: Healthcare Stocks Softer in Afternoon Trading

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVS Health stock logo

CVS Health NYSE:CVS

$88.33 -1.02 (-1.14%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$284.99 -0.76 (-0.27%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$41.88 +0.26 (+0.61%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teva Pharmaceutical Industries stock logo

Teva Pharmaceutical Industries NYSE:TEVA

$43.64 -0.86 (-1.94%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.